Jaye Thompson's Net Worth
$4.32 Million
Who is Jaye Thompson?
Jaye Thompson has an estimated net worth of $4.32 Million. This is based on reported shares across multiple companies, which include Greenwich LifeSciences, Inc., Opexa Therapeutics, Inc., and REPROS THERAPEUTICS INC..
SEC CIK
Jaye Thompson's CIK is 0001476971
Past Insider Trading and Trends
2023 was Jaye Thompson's most active year for acquiring shares with 10 total transactions. Jaye Thompson's most active month to acquire stocks was the month of December. 2022 saw Jaye Thompson paying a total of $61,925.00 for 153,318 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Greenwich LifeSciences, Inc. (GLSI) Snapshot price: $17
VP Clinical Reg Affairs
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.30% | 800 |
$13.85 | $11,080.00 | 263.15K |
Aug 12
| |||
Form 4
| +0.38% | 1K |
$16.00 | $16,000.00 | 261.35K |
Jul 18
| |||
Form 4
| +0.19% | 500 |
$8.57 | $4,285.00 | 260.35K |
Oct 27
| |||
Form 4
| +0.23% | 600 |
$8.71 | $5,226.00 | 259.85K |
Sep 26
| |||
Form 4
| +0.10% | 250 |
$9.49 | $2,372.50 | 259.25K |
Jul 13
| |||
Form 4
| +0.10% | 250 |
$11.22 | $2,805.00 | 259K |
Apr 28
| |||
Form 4
| +0.39% | 1K |
$11.87 | $11,870.00 | 258.75K |
Apr 11
| |||
Form 4
| +0.10% | 250 |
$12.71 | $3,177.50 | 257.75K |
Mar 15
| |||
Form 4
| +0.10% | 250 |
$15.40 | $3,848.75 | 257.5K |
Feb 24
| |||
Form 4
| +0.10% | 250 |
$20.84 | $5,210.00 | 257.25K |
Feb 3
| |||
Form 4
| +0.10% | 250 |
$19.20 | $4,800.00 | 257K |
Jan 27
| |||
Form 4
| +0.10% | 250 |
$16.50 | $4,125.00 | 256.75K |
Jan 13
| |||
Form 4
| +0.10% | 250 |
$12.94 | $3,235.00 | 256.5K |
Dec 16
| |||
Form 4
| +0.10% | 250 |
$13.98 | $3,495.00 | 256.25K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +0.20% | 500 |
$16.74 | $8,370.00 | 256K |
Apr 19
| |||
Form 4
| +0.20% | 500 |
$18.47 | $9,235.00 | 255.5K |
Jan 31
| |||
Form 4
| +0.20% | 500 |
$16.33 | $8,165.00 | 255K |
Jan 21
| |||
Form 4
| +0.20% | 500 |
$18.87 | $9,435.00 | 254.5K |
Jan 18
| |||
Form 4
| +0.40% | 1K |
$19.99 | $19,990.00 | 254K |
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Opexa Therapeutics, Inc. (ACER) Snapshot price: $0.8675
SVP Clinical Dev & Reg Affairs
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REPROS THERAPEUTICS INC. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||